Cargando…

Triage for Potential Percutaneous Coronary Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic

Detalles Bibliográficos
Autores principales:	Liu, Qi, He, Sen, Xiong, Tian-Yuan, Peng, Yong, Wei, Jia-Fu, Li, Chen, Zhu, Ye, Zhang, Li, Wang, Mian, Wang, Hua, Zheng, Ming-Xia, Bao, Yun, Wang, Ya-Li, He, Yong, Chen, Mao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578379/ https://www.ncbi.nlm.nih.gov/pubmed/33134304 http://dx.doi.org/10.3389/fmed.2020.567598

Ejemplares similares

Prognostic significance of troponin increment after percutaneous coronary intervention: A retrospective study
por: Li, Ya, et al.
Publicado: (2022)

Genetic Predisposition to Coronavirus Disease 2019 in Relation to Ten Cardiovascular Conditions: A Two-Sample Mendelian Randomization Study
por: Jia, Min, et al.
Publicado: (2022)

Rationale and design of the OPTIMAL‐REPERFUSION trial: A prospective randomized multi‐center clinical trial comparing different fibrinolysis‐transfer percutaneous coronary intervention strategies in acute ST‐segment elevation myocardial infarction
por: Chen, Zhongxiu, et al.
Publicado: (2021)

Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
por: Zhang, Jinnong, et al.
Publicado: (2020)

A Novel Classification for Predicting Chronic Total Occlusion Percutaneous Coronary Intervention
por: Zhang, Dongfeng, et al.
Publicado: (2022)

Coronavirus disease 2019 death prediction by electrocardiographic abnormalities and elevated D-dimer levels
por: Chen, Jing, et al.
Publicado: (2022)

Oral Chinese Herbal Medicine on Immune Responses During Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Shi, Shihua, et al.
Publicado: (2022)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Triage Room Principles and Recommendations for 2019 Novel Coronavirus
por: Barzanji, Arvin, et al.
Publicado: (2021)

Prognostic Value of a Clinical Biochemistry-Based Nomogram for Coronavirus Disease 2019
por: Yu, Jing, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Prevalence and Mortality of Moderate or Severe Mitral Regurgitation Among Patients Undergoing Percutaneous Coronary Intervention With or Without Heart Failure: Results From CIN Study With 28,358 Patients
por: Huang, Haozhang, et al.
Publicado: (2022)

Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019
por: Luo, Ying, et al.
Publicado: (2020)

Management and implementation strategies of pre-screening triage in children during coronavirus disease 2019 pandemic in Guangzhou, China
por: Shi, Xuan, et al.
Publicado: (2021)

Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study
por: Fan, Yongzhen, et al.
Publicado: (2020)

Triage Modeling for Differential Diagnosis Between COVID-19 and Human Influenza A Pneumonia: Classification and Regression Tree Analysis
por: Xiao, Anling, et al.
Publicado: (2021)

Guideline-Based Chinese Herbal Medicine Treatment Plus Standard Care for Severe Coronavirus Disease 2019 (G-CHAMPS): Evidence From China
por: Ye, Yong-an
Publicado: (2020)

Prevalence, Predictors, and Clinical Presentation of Acute Pericardial Effusion Following Percutaneous Coronary Intervention
por: Zhao, Bei, et al.
Publicado: (2022)

Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Coated Balloon-Only Strategy in de novo Lesions of Large Coronary Arteries
por: Hu, Feng-Wang, et al.
Publicado: (2022)

Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators
por: Zhang, Jian, et al.
Publicado: (2021)

Impact of Thrombocytopenia on In-Hospital Outcome in Patients Undergoing Percutaneous Coronary Intervention
por: Chen, Zhongxiu, et al.
Publicado: (2021)

Vascular surgery triage during the coronavirus disease 2019 pandemic
por: Sarfati, Mark R., et al.
Publicado: (2021)

Prognostic and diagnostic accuracy of intracoronary electrocardiogram recorded during percutaneous coronary intervention: a meta-analysis
por: Li, Weijie, et al.
Publicado: (2022)

Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists
por: Jin, Huijuan, et al.
Publicado: (2020)

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022)

Editorial: Impact of coronavirus disease 2019 (COVID-19) pandemic on nosocomial infection
por: Wang, Mingke, et al.
Publicado: (2023)

Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study
por: Liu, Qing Quan, et al.
Publicado: (2020)

Epidemiological Trends of Coronavirus Disease 2019 in China
por: Chen, Bilin, et al.
Publicado: (2020)

Case Report: Identification of SARS-CoV-2 in Cerebrospinal Fluid by Ultrahigh-Depth Sequencing in a Patient With Coronavirus Disease 2019 and Neurological Dysfunction
por: Xiang, Pan, et al.
Publicado: (2021)

Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019
por: Zhan, Xiao-Yong, et al.
Publicado: (2021)

Percutaneous coronary intervention improves quality of life of patients with chronic total occlusion and low estimated glomerular filtration rate
por: Zhao, Shuai, et al.
Publicado: (2022)

Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
por: Wang, Xiaoyan, et al.
Publicado: (2021)

Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery
por: Gao, Yi-Ping, et al.
Publicado: (2022)

Frailty Predicts Poor Prognosis of Patients After Percutaneous Coronary Intervention: A Meta-Analysis of Cohort Studies
por: Wang, Peng, et al.
Publicado: (2021)

Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
por: Liu, Danfei, et al.
Publicado: (2020)

Janus kinases inhibitors for coronavirus disease-2019: A pairwise and Bayesian network meta-analysis
por: Niu, Jianyi, et al.
Publicado: (2022)

Characteristics and Prognosis of Antibody Non-responders With Coronavirus Disease 2019
por: Ding, Junyu, et al.
Publicado: (2022)

Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention
por: Lai, Wenguang, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tests for Border Screening During the Very Early Phase of Coronavirus Disease 2019 Pandemic: A Systematic Review and Meta-Analysis
por: Chua, Pearleen Ee Yong, et al.
Publicado: (2022)

Percutaneous closure of a fistula from the left circumflex coronary artery to the coronary sinus in an infant
por: Bao, Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mr4428upg32hrgdaqmuhtkajhi